AstraZeneca makes case for use of blood thinner Brilinta in stroke patients

AstraZeneca makes case for use of blood thinner Brilinta in stroke patients

Source: 
Endpoints
snippet: 

AstraZeneca’s extravagant projections for its clot fighter Brilinta may have fizzled in the face of underwhelming trial data — but a new pivotal study is set to expand its use substantially.